RecruitingNCT07114653
The Role of POLE Mutation in High Risk Endometrial Cancer.
Sponsor
Far Eastern Memorial Hospital
Enrollment
150 participants
Start Date
Sep 1, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
The actual role of POLE mutations in high-risk endometrial cancer is undetermined. The main question it aims to answer is: What is the prevalence of POLE mutations in high-risk endometrial cancer case? What is the impact of POLE mutations in real world high-risk endometrial cancer case?
Eligibility
Sex: FEMALE
Inclusion Criteria1
- women with high-risk for recurrent endometrial cancer
Exclusion Criteria1
- Nil
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07114653
Related Trials
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
NCT0711460125 locations
A Study of LY4175408 in Participants With Advanced Cancer
NCT0704692324 locations
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
NCT0658695719 locations
Registry Platform Ovarian and Endometrial Cancer
NCT051299691 location
A Study of DM002 in Patients With Advanced Solid Tumors
NCT067513295 locations